title: Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making.
authors.forename: David R
authors.initials: DR
authors.lastname: Gandara
authors.forename: Primo N
authors.initials: PN
authors.lastname: Lara
authors.forename: Philip
authors.initials: P
authors.lastname: Mack
authors.forename: Giorgio
authors.initials: G
authors.lastname: Scagliotti
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D003657:Decision Making; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D013940:Thymidylate Synthase / Q000235:genetics
chemical_list: D047428:Protein Kinase Inhibitors; D013940:Thymidylate Synthase; D066246:ErbB Receptors